Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial-Reference-Cited by-同舟云学术

Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial

Published:2021-10 Issue:10 Volume:53 Page:1254-1259
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Gallois Claire,Emile Jean-François,Kim Stefano,Monterymard Carole,Gilabert Marine,Bez Jérémie,Lièvre Astrid,Dahan Laetitia,Laurent-Puig Pierre,Mineur Laurent,Coriat Romain,Legoux Jean-Louis,Hautefeuille Vincent,Phelip Jean-Marc,Lecomte Thierry,Sokol Harry,Capron Claude,Randrian Violaine,Lepage Come,Lomenie Nicolas,Kurtz Camille,Taieb Julien,Tougeron David

Funder

Meso Scale Diagnostics

Ligue Contre le Cancer

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations;Tougeron;Mod Pathol,2009

2. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX;Emile;Eur J Cancer,2017

3. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983;Tanis;Eur J Cancer,2015

4. PD-1 blockade in tumors with mismatch-repair deficiency;Le;N Engl J Med,2015

5. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer;André;N Engl J Med,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment;Frontiers in Immunology;2023-09-18

2. A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer;Journal of Gastrointestinal Oncology;2023-04

3. Anti-PD-1 combined with targeted therapy: Theory and practice in gastric and colorectal cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-09

4. The Establishment and Experimental Verification of an lncRNA-Derived CD8+ T Cell Infiltration ceRNA Network in Colorectal Cancer;Clinical Medicine Insights: Oncology;2022-01

5. Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis;Frontiers in Immunology;2021-09-29